Chloroquine containing liposomes in the chemotherapy of murine malaria.
about
A systematic screen of FDA-approved drugs for inhibitors of biological threat agentsInhibition of the Growth of Plasmodium falciparum in Culture by Stearylamine-Phosphatidylcholine Liposomes.Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice.Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria.The parenteral controlled release of liposome encapsulated chloroquine in mice.Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
P2860
Chloroquine containing liposomes in the chemotherapy of murine malaria.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Chloroquine containing liposomes in the chemotherapy of murine malaria.
@en
type
label
Chloroquine containing liposomes in the chemotherapy of murine malaria.
@en
prefLabel
Chloroquine containing liposomes in the chemotherapy of murine malaria.
@en
P2093
P2860
P1433
P1476
Chloroquine containing liposomes in the chemotherapy of murine malaria.
@en
P2093
Crommelin DJ
Huiskamp CW
Peeters PA
P2860
P304
P356
10.1017/S003118200006145X
P478
P577
1989-06-01T00:00:00Z